Stuart Schreiber American chemist
Schreiber, Stuart L.
![Sudoc [ABES], France](/https/viaf.org/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Schreiber, Stuart
Schreiber, Stuart, 1956-
VIAF ID: 58432161 (Personal)
Permalink: http://viaf.org/viaf/58432161
Preferred Forms
-
200 _ |
‡a
Schreiber
‡b
Stuart L.
-
100 1 _
‡a
Schreiber, Stuart
-
100 1 _ ‡a Schreiber, Stuart
-
100 1 _ ‡a Schreiber, Stuart
-
100 1 _
‡a
Schreiber, Stuart
-
100 1 _ ‡a Schreiber, Stuart L
-
100 1 _ ‡a Schreiber, Stuart L.
-
100 1 _ ‡a Schreiber, Stuart L.
-
100 1 _
‡a
Schreiber, Stuart L.
-
100 1 _ ‡a Schreiber, Stuart L.
-
100 1 _ ‡a Schreiber, Stuart L.
-
100 1 _
‡a
Schreiber, Stuart
‡d
1956-
-
100 1 _ ‡a Schreiber, Stuart, ‡d 1956-
-
100 0 _
‡a
Stuart Schreiber
‡c
American chemist
4xx's: Alternate Name Forms (31)
Works
| Title | Sources |
|---|---|
| Additions to C-X[pi]-Bonds |
|
| A chemical approach to understanding and controlling signal transduction, 1994: |
|
| Chemical biology from small molecules to systems biology and drug design |
|
| Comprehensive organic synthesis selectivity, strategy & efficiency in modern organic chemistry |
|
| Diversity-oriented synthesis : basics and applications in organic synthesis, drug discovery, and chemical bilogy |
|
| The NIH's role in accelerating translational sciences |
|
| The Power of Sophisticated Phenotypic Screening and Modern Mechanism-of-Action Methods |
|
| Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development |
|
| The promise and peril of chemical probes |
|
| Quantifying fitness distributions and phenotypic relationships in recombinant yeast populations |
|
| Quantifying structure and performance diversity for sets of small molecules comprising small-molecule screening collections |
|
| Quantitative-proteomic comparison of alpha and Beta cells to uncover novel targets for lineage reprogramming |
|
| Real-Time Biological Annotation of Synthetic Compounds. |
|
| Recent achievements and current trajectories of diversity-oriented synthesis |
|
| Regulation of ferroptotic cancer cell death by GPX4 |
|
| Renal medullary carcinomas depend upon loss and are sensitive to proteasome inhibition |
|
| Revealing complex traits with small molecules and naturally recombinant yeast strains |
|
| Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine |
|
| Ring-opening and ring-closing reactions of a shikimic acid-derived substrate leading to diverse small molecules |
|
| Rpd3p relocation mediates a transcriptional response to rapamycin in yeast |
|
| RWEN: response-weighted elastic net for prediction of chemosensitivity of cancer cell lines |
|
| Screen for Inhibitors of STK33 Kinase Activity |
|
| Screen for RAS-Selective Lethal Compounds and VDAC Ligands - Probe 2 |
|
| Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes. |
|
| Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles |
|
| Selective killing of cancer cells by a small molecule targeting the stress response to ROS |
|
| Selective modulation of autophagy, innate immunity, and adaptive immunity by small molecules |
|
| Short synthesis of skeletally and stereochemically diverse small molecules by coupling petasis condensation reactions to cyclization reactions |
|
| Signaling network model of chromatin |
|
| SIR1, an upstream component in auxin signaling identified by chemical genetics |
|
| Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors |
|
| Small-molecule control of cytokine function: new opportunities for treating immune disorders |
|
| Small-molecule diversity using a skeletal transformation strategy |
|
| Small-molecule enhancers of autophagy modulate cellular disease phenotypes suggested by human genetics |
|
| Small-molecule fluorophores to detect cell-state switching in the context of high-throughput screening |
|
| Small-molecule inducers of insulin expression in pancreatic alpha-cells. |
|
| Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma |
|
| Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease |
|
| Small molecule modulation of the human chromatid decatenation checkpoint |
|
| Small-molecule reagents for cellular pull-down experiments |
|
| Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells. |
|
| Small-Molecule Suppressors of Cytokine-Induced beta-Cell Apoptosis. |
|
| Small-molecule targeting of brachyury transcription factor addiction in chordoma |
|
| Small molecules, big players: the National Cancer Institute's Initiative for Chemical Genetics |
|
| Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. |
|
| Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles |
|
| SpectralNET--an application for spectral graph analysis and visualization |
|
| Stereochemical and skeletal diversity arising from amino propargylic alcohols |
|
| Stereospecific Palladium-Catalyzed C-H Arylation of Pyroglutamic Acid Derivatives at the C3 Position Enabled by 8-Aminoquinoline as a Directing Group |
|
| STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability |
|
| Structural basis of malaria parasite phenylalanine tRNA-synthetase inhibition by bicyclic azetidines. |
|
| Structural Biasing Elements for In-Cell Histone Deacetylase Paralog Selectivity |
|
| Structure-activity relationships of GPX4 inhibitor warheads |
|
| Synergistic Effects of Stereochemistry and Appendages on the Performance Diversity of a Collection of Synthetic Compounds |
|
| Syntheses of aminoalcohol-derived macrocycles leading to a small-molecule binder to and inhibitor of Sonic Hedgehog |
|
| Syntheses of α-pyrones using gold-catalyzed coupling reactions |
|
| Synthesis and conformation-activity relationships of the peptide isosteres of FK228 and largazole |
|
| Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs |
|
| Synthesis of a Bicyclic Azetidine with In Vivo Antimalarial Activity Enabled by Stereospecific, Directed C(sp3)-H Arylation |
|
| Synthesis of calcineurin-resistant derivatives of FK506 and selection of compensatory receptors |
|
| Synthesis of oxazocenones via gold(I)-catalyzed 8-endo-dig hydroalkoxylation of alkynamides |
|
| Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis |
|
| Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity |
|
| Targeting Dependency on the GPX4 Lipid Peroxide Repair Pathway for Cancer Therapy. |
|
| Total synthesis and biological mode of action of largazole: a potent class I histone deacetylase inhibitor |
|
| Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling |
|
| Towards a treatment for genetic prion disease: trials and biomarkers |
|
| Towards Diversity-Oriented, Stereoselective Syntheses of Biaryl- or Bis(aryl)metal-Containing Medium Rings |
|
| Towards patient-based cancer therapeutics |
|
| Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms |
|
| Unbiased discovery of in vivo imaging probes through in vitro profiling of nanoparticle libraries |
|
| Unifying principles of bifunctional, proximity-inducing small molecules |
|
| US immigration order strikes against biotech. |
|
| The use of chromatin immunoprecipitation assays in genome-wide analyses of histone modifications |
|
| Using expression and genotype to predict drug response in yeast |
|
| Using genome-wide transcriptional profiling to elucidate small-molecule mechanism |
|
| Vector algebra in the analysis of genome-wide expression data |
|
| Water-Compatible Cycloadditions of Oligonucleotide-Conjugated Strained Allenes for DNA-Encoded Library Synthesis |
|
| Whole Genome Amplification by T7-Based Linear Amplification of DNA (TLAD): Overview |
|
